Fibrosis in Hodgkin and non-Hodgkin lymphomas

被引:12
|
作者
Tataroglu, Canten [1 ]
Sarioglu, Suelen
Kargi, Aydanur
Ozkal, Sermin
Aydin, Oezlem
机构
[1] Adnan Menderes Univ, Sch Med, Dept Pathol, TR-09100 Aydin, Turkey
[2] Dokuz Eylul Univ, Sch Med, Dept Pathol, Izmir, Turkey
[3] Mersin Univ, Sch Med, Dept Pathol, Mersin, Turkey
关键词
lymphoma; fibrosis; quantitative histochemistry; mast cells;
D O I
10.1016/j.prp.2007.07.006
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
There is little quantitative information about the amount of fibrosis in lymphomas. The aim of the present study was to investigate the amount of fibrosis in lymphomas and to highlight the relationship between fibrosis and mast cells, the key players of fibrosis. Tissue sections of 60 patients with diagnosis of lymphoma were reevaluated for classification. The mean fibroticstained area percentage (F-SAP) was determined in van Gieson-stained digital images using image analysis (Mediscope, Dokuz Eylul University, Clinical Engineering, Turkey). Mast cells were visualized using streptavidin peroxidase immunohistochemistry with anti-tryptase staining. Twenty-seven. (44%) cases were Hodgkin's lymphoma (HL). F-SAP was 11.09 +/- 8.96 and 1.72 +/- 1.76 for HL and non-HL cases (Mann-Whitney U, p < 0.000), and the mean mast cell count (MMCC) was 24.63 +/- 13.58 and 8.03 +/- 8.07, respectively (Mann-Whitney U test, p < 0.000). There was a significant difference between F-SAP and MMCC concerning different types of lymphomas (Kruskal-Wallis test, p > 0.000). F-SAP was highest in nodular sclerosis HL, and MMCC was highest in mixed cellular HL. There was a strong positive correlation between MMCC and F-SAP (Pearson Correlation test, p < 0.000, r = 0. 5 1). These results suggest that the amount of fibrosis demonstrates differences in subtypes of lymphomas, and mast cells are increased in fibrosing lymphomas. However, it seems likely that more than one cell type is involved. < 2007 Elsevier GrnbH. All rights reserved.
引用
收藏
页码:725 / 730
页数:6
相关论文
共 50 条
  • [1] NON-HODGKIN LYMPHOMAS
    WEIL, M
    JACQUILLAT, C
    DUMONT, J
    [J]. NOUVELLE PRESSE MEDICALE, 1981, 10 (27): : 2255 - 2256
  • [2] NON-HODGKIN LYMPHOMAS
    JONES, SE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 234 (06): : 633 - 638
  • [3] Hodgkin's and Non-Hodgkin's lymphomas
    Rademaker, Juergen
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2007, 45 (01) : 69 - +
  • [4] Prognostic factors in Hodgkin and non-Hodgkin lymphomas
    Cuenca, X.
    Xhaard, A.
    Mounier, N.
    [J]. BULLETIN DU CANCER, 2009, 96 (04) : 461 - 473
  • [5] Hodgkin's disease and non-Hodgkin lymphomas
    Gutiérrez, EO
    [J]. REVISTA CLINICA ESPANOLA, 1999, 199 : 44 - 51
  • [6] CYTOPHOTOMETRIC MEASUREMENTS OF THE DNA IN HODGKIN LYMPHOMAS AND NON-HODGKIN LYMPHOMAS
    ADLER, CP
    RIEDE, UN
    WURDAK, W
    ZUGMAIER, G
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1984, 178 (06) : 579 - 589
  • [7] Radiotherapy for Non-Hodgkin Lymphomas
    Imber, Brandon S.
    Yahalom, Joachim
    [J]. CANCER JOURNAL, 2020, 26 (03): : 217 - 230
  • [9] CLASSIFICATION OF NON-HODGKIN LYMPHOMAS
    DONHUIJSEN, K
    LEDER, LD
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (01) : 37 - 37
  • [10] Non-Hodgkin's Lymphomas
    Zelenetz, Andrew D.
    Abramson, Jeremy S.
    Advani, Ranjana H.
    Andreadis, C. Babis
    Byrd, John C.
    Czuczman, Myron S.
    Fayad, Luis
    Forero, Andres
    Glenn, Martha J.
    Gockerman, Jon P.
    Gordon, Leo I.
    Harris, Nancy Lee
    Hoppe, Richard T.
    Horwitz, Steven M.
    Kaminski, Mark S.
    Kim, Youn H.
    LaCasce, Ann S.
    Mughal, Tariq I.
    Nademanee, Auyporn
    Porcu, Pierluigi
    Press, Oliver
    Prosnitz, Leonard
    Reddy, Nashitha
    Smith, Mitchell R.
    Sokol, Lubomir
    Swinnen, Lode
    Vose, Julie M.
    Wierda, William G.
    Yahalom, Joachim
    Yunus, Furhan
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (03): : 288 - 334